CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-15 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise | +13,100 | 57,846 | ||
| 2025-03-15 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise | +10,000 | 67,846 | ||
| 2025-03-15 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −13,100 | 26,200 | ||
| 2025-03-15 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −10,000 | 30,000 | ||
| 2025-03-15 | Kaye Edward M. MD CEO | Option exercise | +35,500 | 132,385 | ||
| 2025-03-15 | Kaye Edward M. MD CEO | Option exercise | +26,250 | 158,635 | ||
| 2025-03-15 | Kaye Edward M. MD CEO | Option exercise · Restricted Stock Units | −35,500 | 71,000 | ||
| 2025-03-15 | Kaye Edward M. MD CEO | Option exercise · Restricted Stock Units | −26,250 | 78,750 | ||
| 2024-12-30 | Kaye Edward M. MD CEO | Option exercise | +35,000 | $0.60 | $21K | 96,885 |
| 2024-12-30 | Kaye Edward M. MD CEO | Option exercise · Employee Stock Option (Right to Buy) | −35,000 | 567,801 | ||
| 2024-12-23 | Skorpios Trust 10% owner | Sale | −2,000,000 | $11.50 | $23.0M | 6,906,181 |
| 2024-12-09 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | −2,586 | $12.99 | $34K | 44,746 |
| 2024-12-09 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −12,114 | $13.69 | $166K | 23,028 |
| 2024-12-09 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −1,552 | $12.99 | $20K | 21,476 |
| 2024-12-09 | Kaye Edward M. MD CEO | Sale | −6,786 | $12.99 | $88K | 61,885 |
| 2024-12-01 | Kaye Edward M. MD Director | Option exercise | +4,317 | 53,441 |
Page 13 of 13 · 256 trades